Related Experiment Videos
The Medtronic-Hall prosthesis in multiple valve replacement--first results
Insights
The Medtronic-Hall prosthesis demonstrated no thromboembolic events in multiple valve replacements. Slight hemolysis was noted, with rare periprosthetic leaks in this cardiac surgery study.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
Background:
- The Medtronic-Hall prosthesis is utilized for valve replacement surgery.
- Multiple valve replacements present unique surgical challenges and outcomes.
- Assessing the long-term efficacy and safety of prosthetic valves is crucial.
Purpose of the Study:
- To evaluate the outcomes of multiple valve replacements using the Medtronic-Hall prosthesis.
- To analyze complications such as thromboembolism, periprosthetic leaks, and hemolysis.
Main Methods:
- Retrospective analysis of 107 patients undergoing valve replacement with the Medtronic-Hall prosthesis between January 1981 and September 1982.
- Focus on 34 patients with multiple valve replacements, including tricuspid valve procedures.
- Clinical data collection on mortality, thromboembolic events, periprosthetic leaks, and hemolysis.
Main Results:
- Two hospital deaths (5.8%) and one late death occurred.
- No thromboembolic episodes were recorded in the study cohort.
- Two instances of periprosthetic leak were identified, one associated with bacterial endocarditis.
- Constant, mild hemolysis was observed in all patients.
Conclusions:
- The Medtronic-Hall prosthesis appears safe regarding thromboembolic complications in multiple valve replacement settings.
- Periprosthetic leaks and endocarditis remain potential complications requiring vigilant monitoring.
- Mild hemolysis is a consistent finding but may not have significant hemodynamic impact.
Abstract:
From January 1981 to September 1982, 107 patients have been operated on for valve replacement with the Medtronic-Hall (M-H) prosthesis. Thirty-four of them have had multiple valve replacements and they are the subject of this paper. In 2 cases there were tricuspid replacement, and in 9 other patients some type of tricuspid annuloplasty was performed. There were 2 hospital deaths (5.8%) and one late death. No thromboembolic episodes were recorded in this series of patients. In 2 instances a periprosthetic leak was detected. One of these was in a woman with an aortic and mitral valve replacement due to bacterial endocarditis. In this patient a diastolic aortic murmur was registered 4 months after the operation without hemodynamic repercussion. The other patient had endocarditis with positive blood cultures (S. epidermidis) one year after the operation and showed severe hemodynamic deterioration. The patient was re-operated on and the mitral prosthesis was replaced by another with the same characteristics. The patient is doing well. A constant but slight degree of hemolysis was found in every patient in the group.